The immune phenotyping and immune functionality analyses ex vivo thereby substantiate the association of the ATG16L1 genotype with phenotypically improved clinical disease outcomes and superior CD4+ and CD8+ T cell immunity in chronic HIV-1 infection. Here, CD4 is linked to HIV-1 infection.